INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Building A Resilient Supply Chain For Your Next-Generation Peptide Therapeutic

  As peptide therapeutics continue to establish themselves as a leading technology for treating chronic indications, drug sponsors must identify reliable peptide building block suppliers to secure high-quality starting materials.

• Accelerating Cold Chain Expansion: Responding To COVID-19 Challenges

  Review how leveraging cross-functional teamwork helped complete a cold chain infrastructure expansion in a fraction of the expected timeline, ensuring the production of essential COVID-19 therapeutics.

• Food Safety Digital Maturity In The Supply Chain

  Look at how connected data and automated processes strengthen safety, improve traceability, and streamline compliance across the supply chain—offering a clear roadmap for progression.

• Integrated Single-Site CDMO Model

  A single‑site model reduces handoff risks, speeds timelines, strengthens quality oversight, and unifies development and manufacturing to improve reliability and execution efficiency.

• Biopharma Supply, Reimagined: Regional, Resilient Manufacturing

  4/1/2026

  Persistent disruption is redefining biopharma supply chains. Explore how regional manufacturing, integrated risk management, and closer collaboration help build resilience and improve agility.

• Clinical, Commercial Packaging: Delivering Next-Gen Therapies

  4/7/2026

  See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.

• Global Strategies For Resilience And Redundancy In Cell Culture Media Supply

  7/17/2025

  Ensure your cell culture media supply remains uninterrupted. Explore proactive strategies for global manufacturing equivalency and consistent media delivery.

• The Future Of RNA Manufacturing Starts With Raw Material Innovation

  2/11/2026

  Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are exploring how to make critical raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.

• From LAL To rFC: The Evolution Of Endotoxin Testing

  6/26/2026

  Protect patient safety and ensure regulatory compliance by implementing sensitive, reliable bacterial endotoxin testing as a critical component of pharmaceutical quality assurance.